Biomaterials Market
Biomaterials Market Size, Share, Growth & Industry Analysis, By Application (Orthopedics, Cardiology, Ophthalmology, Plastic Surgery, Wound Healing, Dental, Others), By Material Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Others), and Regional Analysis, 2024-2031
Pages : 140
Base Year : 2023
Release : December 2024
Report ID: KR1165
TABLE OF CONTENT
1 INTRODUCTION OF THE GLOBAL BIOMATERIALS MARKET
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach
4 GLOBAL BIOMATERIALS MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis
5 IMPACT OF RUSSIA-UKRAINE WAR
6 GLOBAL BIOMATERIALS MARKET, BY APPLICATION
6.1 Overview
6.2 Orthopedics
6.2.1 Joint replacements
6.2.2 Bone grafts and implants
6.2.3 Spinal implants
6.2.4 Others
6.3 Cardiology
6.3.1 Stents
6.3.2 Heart valves
6.3.3 Vascular grafts
6.3.4 Others
6.4 Ophthalmology
6.4.1 Intraocular lenses
6.4.2 Contact lenses
6.4.3 Synthetic Corneas
6.4.4 Others
6.5 Plastic Surgery
6.5.1 Soft Tissue Fillers
6.5.2 Facial Winkle Treatment Devices
6.5.3 Others
6.6 Wound Healing
6.6.1 Wound Closure Devices
6.6.2 Internal Tissue Sealants
6.6.3 Skin Subsititutes
6.6.4 Others
6.7 Dental
6.7.1 Tissue Regeneration Materials
6.7.2 Dental Implants
6.7.3 Bone Grafts & Substitutes
6.8 Others
7 GLOBAL BIOMATERIALS MARKET, BY MATERIAL TYPE
7.1 Overview
7.2 Metallic Biomaterials
7.2.1 Stainless Steel
7.2.2 Titanium and Titanium Alloy
7.2.3 Others
7.3 Polymeric Biomaterials
7.3.1 Silicone
7.3.2 Polyurethanes
7.3.3 Polyesters
7.3.4 Others
7.4 Ceramic Biomaterials
7.4.1 Alumina
7.4.2 Zirconia
7.4.3 Others
7.5 Others
8 GLOBAL BIOMATERIALS MARKET, BY END USE
8.1 Overview
8.2 Medical Diagnostics
8.3 Medical Therapeutics
8.4 Non-medical Applications
9 GLOBAL BIOMATERIALS MARKET, BY GEOGRAPHY
9.1 Overview
10 NORTH AMERICA
10.1 U.S.
10.2 Canada
10.3 Mexico
11 EUROPE
11.1 Germany
11.2 U.K.
11.3 France
11.4 Italy
11.5 Spain
11.6 Russia
11.7 Rest of Europe
12 ASIA-PACIFIC
12.1 China
12.2 Japan
12.3 India
12.4 South Korea
12.5 Rest of Asia-Pacific
13 MIDDLE EAST & AFRICA
13.1 GCC
13.2 South Africa
13.3 North Africa
13.4 Rest of Middle East & Africa
14 LATIN AMERICA
14.1 Brazil
14.2 Argentina
14.3 Rest of South America
15 GLOBAL BIOMATERIALS MARKET COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Key Developments
15.3 Key Strategic Developments
15.4 Company Market Ranking
15.5 Regional Footprint
15.6 Industry Footprint
16 COMPANY PROFILES
16.1 Evonik Industries AG.
16.1.1 Key Facts
16.1.2 Financial Overview
16.1.3 Product Benchmarking
16.1.4 Recent Developments
16.1.5 Winning Imperatives
16.1.6 Current Focus & Strategies
16.1.7 Threat from competition
16.1.8 SWOT Analysis
16.2 CAM Bioceramics B.V.
16.2.1 Key Facts
16.2.2 Financial Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments
16.2.5 Winning Imperatives
16.2.6 Current Focus & Strategies
16.2.7 Threat from competition
16.2.8 SWOT Analysis
16.3 GELITA AG
16.3.1 Key Facts
16.3.2 Financial Overview
16.3.3 Product Benchmarking
16.3.4 Recent Developments
16.3.5 Winning Imperatives
16.3.6 Current Focus & Strategies
16.3.7 Threat from competition
16.3.8 SWOT Analysis
16.4 dsm-firmenich.
16.4.1 Key Facts
16.4.2 Financial Overview
16.4.3 Product Benchmarking
16.4.4 Recent Developments
16.4.5 Winning Imperatives
16.4.6 Current Focus & Strategies
16.4.7 Threat from competition
16.4.8 SWOT Analysis
16.5 Victrex plc
16.5.1 Key Facts
16.5.2 Financial Overview
16.5.3 Product Benchmarking
16.5.4 Recent Developments
16.5.5 Winning Imperatives
16.5.6 Current Focus & Strategies
16.5.7 Threat from competition
16.5.8 SWOT Analysis
16.6 CoorsTek Inc.
16.6.1 Key Facts
16.6.2 Financial Overview
16.6.3 Product Benchmarking
16.6.4 Recent Developments
16.7 Zeus Company LLC
16.7.1 Key Facts
16.7.2 Financial Overview
16.7.3 Product Benchmarking
16.7.4 Recent Developments
16.8 Celanese Corporation
16.8.1 Key Facts
16.8.2 Financial Overview
16.8.3 Product Benchmarking
16.8.4 Recent Developments
16.9 Corbion.
16.9.1 Key Facts
16.9.2 Financial Overview
16.9.3 Product Benchmarking
16.9.4 Recent Developments
16.10 CeramTec GmbH
16.10.1 Key Facts
16.10.2 Financial Overview
16.10.3 Product Benchmarking
16.10.4 Recent Developments
LIST OF TABLES
TABLE 1 Global Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 2 Global Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 3 Global Biomaterials Market Revenue, By Geography, 2021 – 2031 (USD Million)
TABLE 4 North America Biomaterials Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 5 North America Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 6 North America Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 7 US Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 8 US Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 9 Canada Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 10 Canada Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 11 Mexico Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 12 Mexico Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 13 Europe Biomaterials Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 14 Europe Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 15 Europe Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 16 Germany Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 17 Germany Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 18 France Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 19 France Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 20 U.K. Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 21 U.K. Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 22 Spain Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 23 Spain Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 24 Italy Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 25 Italy Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 26 Russia Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 27 Russia Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 28 Rest of Europe Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 29 Rest of Europe Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 30 Asia-Pacific Biomaterials Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 31 Asia-Pacific Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 32 Asia-Pacific Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 33 China Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 34 China Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 35 Japan Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 36 Japan Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 37 India Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 38 India Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 39 South Korea Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 40 South Korea Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 41 Rest of Asia-Pacific Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 42 Rest of Asia-Pacific Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 43 Middle East and Africa Biomaterials Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 44 Middle East and Africa Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 45 Middle East and Africa Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 46 GCC Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 47 GCC Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 48 North Africa Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 49 North Africa Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 50 South Africa Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 51 South Africa Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 52 Rest of Middle East & Africa Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 53 Rest of Middle East & Africa Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 54 Latin America Biomaterials Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 55 Latin America Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 56 Latin America Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 57 Brazil Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 58 Brazil Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 59 Argentina Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 60 Argentina Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 61 Rest of Latin America Biomaterials Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 62 Rest of Latin America Biomaterials Market Revenue, By Material Type, 2021 – 2031 (USD Million)
TABLE 63 Company Market Ranking
TABLE 64 Regional Footprint
TABLE 65 Product Benchmarking
TABLE 66 Recent Developments
TABLE 67 Winning Imperatives
LIST OF FIGURES
FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Biomaterials Market 2021-2031 (USD Million)
FIG. 4 Global Biomaterials Market Geographical Analysis (CAGR %)
FIG. 5 Global Biomaterials Absolute Market Opportunity (USD Million)
FIG. 6 Global Biomaterials Market Attractiveness (USD Million)
FIG. 7 Global Biomaterials Market, By Application, 2021-2031 (USD Million)
FIG. 8 Global Biomaterials Market, By Material Type, 2021-2031 (USD Million)
FIG. 9 Research Methodology
FIG. 10 Research Process
FIG. 11 Bottom-Up Approach
FIG. 12 Top-Bottom Approach
FIG. 13 Market Dynamics Overview
FIG. 14 Porter's Five Forces Analysis
FIG. 15 Value Chain Analysis
FIG. 16 Macroeconomic Analysis
FIG. 17 Global Biomaterials Market Revenue Share, By Application, 2023 and 2031 (%)
FIG. 18 Global Biomaterials Market Revenue Share, By Material Type, 2023 and 2031 (%)
FIG. 19 Global Biomaterials Market Revenue Share, By Geographic Regions, 2023 and 2031 (%)
FIG. 20 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 21 North America Biomaterials Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 22 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 23 Europe Biomaterials Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 25 Asia-Pacific Biomaterials Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 27 Middle East & Africa Biomaterials Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 29 Latin America Biomaterials Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Key Strategic Development
FIG. 31 Key Facts
FIG. 32 Financial Overview
FIG. 33 SWOT Analysis